Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.

Source:http://linkedlifedata.com/resource/pubmed/id/16237064

J. Immunol. 2005 Nov 1 175 9 5732-43

Download in:

View as

Triples

General Info

PMID
16237064